Image enhancement techniques on deep learning approaches for automated diagnosis of COVID-19 features using CXR images

The outbreak of novel coronavirus (COVID-19) disease has infected more than 135.6 million people globally. For its early diagnosis, researchers consider chest X-ray examinations as a standard screening technique in addition to RT-PCR test. Majority of research work till date focused only on application of deep learning approaches that is relevant but lacking in better pre-processing of CXR images. Towards this direction, this study aims to explore cumulative effects of image denoising and enhancement approaches on the performance of deep learning approaches. Regarding pre-processing, suitable methods for X-ray images, Histogram equalization, CLAHE and gamma correction have been tested individually and along with adaptive median filter, median filter, total variation filter and gaussian denoising filters. Proposed study compared eleven combinations in exploration of most coherent approach in greedy manner. For more robust analysis, we compared ten CNN architectures for performance evaluation with and without enhancement approaches. These models are InceptionV3, InceptionResNetV2, MobileNet, MobileNetV2, Vgg19, NASNetMobile, ResNet101, DenseNet121, DenseNet169, DenseNet201. These models are trained in 4-way (COVID-19 pneumonia vs Viral vs Bacterial pneumonia vs Normal) and 3-way classification scenario (COVID-19 vs Pneumonia vs Normal) on two benchmark datasets. The proposed methodology determines with TVF + Gamma, models achieve higher classification accuracy and sensitivity. In 4-way classification MobileNet with TVF + Gamma achieves top accuracy of 93.25% with 1.91% improvement in accuracy score, COVID-19 sensitivity of 98.72% and F1-score of 92.14%. In 3-way classification our DenseNet201 with TVF + Gamma gains accuracy of 91.10% with improvement of 1.47%, COVID-19 sensitivity of 100% and F1-score of 91.09%. Proposed study concludes that deep learning modes with gamma correction and TVF + Gamma has superior performance compared to state-of-the-art models. This not only minimizes overlapping between COVID-19 and virus pneumonia but advantageous in time required to converge best possible results.